Cargando…

Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma

The treatment of paediatric Hodgkin lymphoma (HL) has steadily improved over the years, so that 10- years survival exceed 80%. The purpose of this study was to identify prognostic markers for relapsed HL that might contribute to optimize therapeutic approaches. To this aim we retrospectively analyse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Repetto, Ombretta, Mussolin, Lara, Elia, Caterina, Martina, Lia, Bianchi, Maurizio, Buffardi, Salvatore, Sala, Alessandra, Burnelli, Roberta, Mascarin, Maurizio, De Re, Valli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299395/ https://www.ncbi.nlm.nih.gov/pubmed/30588249 http://dx.doi.org/10.7150/jca.27560

Ejemplares similares

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
por: Repetto, Ombretta, et al.
Publicado: (2021)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
por: De Re, Valli, et al.
Publicado: (2022)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma
por: De Re, Valli, et al.
Publicado: (2017)

Prospective Evaluation of Different Methods for Volumetric Analysis on [(18)F]FDG PET/CT in Pediatric Hodgkin Lymphoma
por: Lopci, Egesta, et al.
Publicado: (2022)

Plasma Cell-Free DNA in Paediatric Lymphomas
por: Mussolin, Lara, et al.
Publicado: (2013)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
por: Garaventa, Alberto, et al.
Publicado: (2022)

Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol
por: Lopci, Egesta, et al.
Publicado: (2021)

Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?
por: Farruggia, Piero, et al.
Publicado: (2016)

Comparison of Hodgkin’s Lymphoma in Children and Adolescents. A Twenty Year Experience with MH’96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols
por: Burnelli, Roberta, et al.
Publicado: (2020)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
por: Daw, Stephen, et al.
Publicado: (2020)

Molecular Signature in HCV-Positive Lymphomas
por: De Re, Valli, et al.
Publicado: (2012)

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
por: Veltri, Giulia, et al.
Publicado: (2022)

Primary breast lymphoma of childhood: a case report and review of literature
por: Restivo, Giulia A., et al.
Publicado: (2021)

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
por: Harker-Murray, Paul, et al.
Publicado: (2023)

Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma
por: Giagnuolo, Giovanna, et al.
Publicado: (2019)

Minimal Disease Monitoring in Pediatric Non-Hodgkin’s Lymphoma: Current Clinical Application and Future Challenges
por: Mussolin, Lara, et al.
Publicado: (2021)

A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
por: Annibali, Ombretta, et al.
Publicado: (2021)

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies
por: Damanti, Carlotta C., et al.
Publicado: (2021)

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer
por: Repetto, Ombretta, et al.
Publicado: (2021)

Extranodal Biphenotypic Non-Hodgkin Lymphoma of the Popliteal Cavity: A Case Report and Review of Literature
por: Restivo, Giulia A., et al.
Publicado: (2022)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Cutaneous Localization of Classic Hodgkin Lymphoma Associated with Mycosis Fungoides: Report of a Rare Event and Review of the Literature
por: Zanelli, Magda, et al.
Publicado: (2021)

T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications
por: Fozza, Claudio, et al.
Publicado: (2011)

Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma
por: Agrusa, Jennifer E., et al.
Publicado: (2020)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

Primary Non-Hodgkin's Lymphoma of the Vulva: A Case Report and Literature Review
por: Clemente, Nicolò, et al.
Publicado: (2016)

Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
por: Fozza, Claudio, et al.
Publicado: (2011)

The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
por: Bari, Alessia, et al.
Publicado: (2019)

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
por: De Re, Valli, et al.
Publicado: (2017)

The seed nuclear proteome
por: Repetto, Ombretta, et al.
Publicado: (2012)

Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience
por: Lovisa, Federica, et al.
Publicado: (2021)

P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report
por: Zerbi, Caterina, et al.
Publicado: (2022)

Methodological framework for radiomics applications in Hodgkin’s lymphoma
por: Sollini, Martina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jddccvpcif5oek251bivcgj903